Drug-Eluting Balloons

This channel includes news and new technology innovations for drug coated balloons, also referred to as drug-eluting balloons. These are used to treat peripheral and coronary artery lesions and restenosis.

Medtronic, In.Pact Admiral drug-coated balloon, trial data, VIVA
News | Drug-Eluting Balloons | September 22, 2016

September 22, 2016 — New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the...

Medtronic, IN.PACT Admiral drug-coated balloon, DCB, FDA approval, in-stent restenosis, ISR
Technology | Drug-Eluting Balloons | September 19, 2016

September 19, 2016 — Medtronic plc announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT...

VIVA 2016, late breaking trials, cath lab
Feature | Cath Lab | September 14, 2016

Vascular Interventional Advances (VIVA) 2016 released its list late-breaking research presentations in vascular...

Medtronic, In.Pact Admiral drug coated balloon, DCB, FDA approval, 150 mm length
Technology | Drug-Eluting Balloons | July 18, 2016

July 18, 2016 — Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT Admiral...

News | Drug-Eluting Balloons | June 03, 2016

June 3, 2016 — Cardionovum GmbH recently announced the completion of enrollment of the RAPID trial. Results will be...

Intact Vascular, Tack Endovascular System

The Intact Vascular Tack Endovascular System is designed to spot stent dissections with a short, self-expanding 6 mm long stent that can expand to vessel diameters between 2.5-6 mm, so exact sizing is not needed.

Feature | Peripheral Artery Disease (PAD) | February 22, 2016 | Dave Fornell

It is estimated that more than 10 million people in the United States are affected by...

Medtronic, CE Mark, IN.PACT Admiral DEB, arteriovenous AV access, hemodialysis, end-stage renal disease patients
News | Drug-Eluting Balloons | January 18, 2016

January 18, 2016 — Medtronic plc announced that the IN.PACT Admiral ...

ISAR-DESIRE 4 trial, TCT 2015, drug-coated balloon, DCB, scoring balloon, SCB, drug-eluting stent restenosis

Image courtesy of Medtronic

Feature | Drug-Eluting Balloons | October 22, 2015

October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a...

IN.PACT SFA study, TCT 2015, drug-coated balloons, PTA, SFA disease, superficial femoral artery

Image courtesy of Medtronic

Feature | Peripheral Artery Disease (PAD) | October 18, 2015

October 18, 2015 — Two-year results from the IN.PACT SFA study found the use of a...

Lutonix Global Real-World Registry results, TCT 2015, Lutonix 035 DCB, peripheral arterial disease, PAD

Image courtesy of C.R. Bard

News | Drug-Eluting Balloons | October 15, 2015

October 15, 2015 — C. R. Bard Inc. announced the presentation of the 12-month results from the Lutonix Global Real-...

News | Cath Lab | August 26, 2015

August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report...

C.R. Bard, LEVANT 2 results, Lutonix 035 DCB, drug coated balloon, PTA
Feature | Drug-Eluting Balloons | July 08, 2015

July 8, 2015 - C.R. Bard Inc. announced the publication of results from the LEVANT 2 study in the June 24, 2015,...

Lutonix DCB, CMS, reimbursement, pass-through payment, outpatient use
News | Drug-Eluting Balloons | June 11, 2015

June 11, 2015 - C.R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved...

IN.PACT Admiral, Global Study, DEB SFA-LONG, long peripheral lesions, EuroPCR
News | May 22, 2015

May 22, 2015 — New clinical data from two different studies...

Stellarex, Spectranetics, investment, BTK, peripheral artery disease
News | May 06, 2015

May 6, 2015 — The Spectranetics Corporation announced it is accelerating investments in the Stellarex...

Overlay Init